Task: Answer the multiple-choice question.
Query: Which drug exhibits a 15.061% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) COC(=O)c1cc(C(=O)OCC(=O)NNC(=O)c2cccs2)cc([N+](=O)[O-])c1
b.) CC(CCc1ccccc1)NC(=O)CN1CCSc2ccccc21
c.) Cc1ccc(OCCOc2cccc(C=C3C(=O)NC(=O)NC3=O)c2)c(C)c1
d.) CCN1CCN(C(=S)NCc2ccc(C)cc2)CC1
Answer: b. CC(CCc1ccccc1)NC(=O)CN1CCSc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CCc1ccccc1)NC(=O)CN1CCSc2ccccc21
CC(CCc1ccccc1)NC(=O)CN1CCSc2ccccc21
2-(2,3-dihydro-1,4-benzothiazin-4-yl)-N-(4-phenylbutan-2-yl)acetamide